Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

British Journal of Cancer
  • View all journals
  • Search
  • Log in
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. british journal of cancer
  3. experimental oncology
  4. article
HLA class I gene expression on human primary tumours and autologous metastases: demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas
Download PDF
Download PDF
  • Experimental Oncology
  • Published: 01 February 1989

HLA class I gene expression on human primary tumours and autologous metastases: demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas

  • MA López-Nevot1,
  • F Esteban,
  • A Ferrón,
  • J Gutiérrez,
  • MR Oliva,
  • C Romero,
  • C Huelin,
  • F Ruiz-Cabello &
  • …
  • F Garrido 

British Journal of Cancer volume 59, pages 221–226 (1989) Cite this article

  • 1123 Accesses

  • 120 Citations

  • Metrics details

Abstract

The expression of HLA class I antigens was studied in 99 primary tumour (colorectal, gastric and laryngeal carcinomas) and 57 autologous metastases using immunohistological techniques and monoclonal antibodies against class I monomorphic determinants, HLA-B isotypic determinants and HLA polymorphic determinants. Fourteen per cent of colorectal, 9.6% of gastric and 20% of laryngeal carcinomas completely lacked class I molecules. Selective losses of HLA-B antigens were also detected in 8.8, 3.4 and 5.8% of these tumours respectively. Taking into account complete and selective loss of HLA-B the average alteration in the class I molecules expression totalled 21%. The comparison of class I expression between primary tumours and autologous metastases showed differences in 24% of the patients. These differences consisted mainly in a decrease of class I expression by metastases. Nevertheless, four types of divergence were detected in laryngeal carcinomas, namely: +/-, +/+, -/+, -/-. In addition, a clear correlation between degree of differentiation and class I expression was observed in laryngeal tumours. Finally, when class I gene RFLPs were compared with DNA from 15 tumours and autologous normal mucosa or peripheral lymphocytes, no differences were detected between these samples.

Similar content being viewed by others

HLA class I expression shapes the tumor immune microenvironment and influences prognosis in prostate cancer

Article Open access 25 October 2025

Expression of HLA class I is associated with immune cell infiltration and patient outcome in breast cancer

Article Open access 27 November 2022

Immunogenetic clustering of 30 cancers

Article Open access 04 May 2022

Article PDF

Author information

Authors and Affiliations

  1. Servicio de Análisis Clínicos, Hospital Virgen de las Nieves, Granada, Spain

    MA López-Nevot

Authors
  1. MA López-Nevot
    View author publications

    Search author on:PubMed Google Scholar

  2. F Esteban
    View author publications

    Search author on:PubMed Google Scholar

  3. A Ferrón
    View author publications

    Search author on:PubMed Google Scholar

  4. J Gutiérrez
    View author publications

    Search author on:PubMed Google Scholar

  5. MR Oliva
    View author publications

    Search author on:PubMed Google Scholar

  6. C Romero
    View author publications

    Search author on:PubMed Google Scholar

  7. C Huelin
    View author publications

    Search author on:PubMed Google Scholar

  8. F Ruiz-Cabello
    View author publications

    Search author on:PubMed Google Scholar

  9. F Garrido
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

López-Nevot, M., Esteban, F., Ferrón, A. et al. HLA class I gene expression on human primary tumours and autologous metastases: demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas. Br J Cancer 59, 221–226 (1989). https://doi.org/10.1038/bjc.1989.45

Download citation

  • Issue date: 01 February 1989

  • DOI: https://doi.org/10.1038/bjc.1989.45

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

This article is cited by

  • HLA class I alterations in breast carcinoma are associated with a high frequency of the loss of heterozygosity at chromosomes 6 and 15

    • María A. Garrido
    • Teresa Rodriguez
    • Natalia Aptsiauri

    Immunogenetics (2018)

  • Down-regulation of HLA-A mRNA in peripheral blood mononuclear cell of colorectal cancer

    • Ming-Chen Zhu
    • Yi-Jun Xu
    • Feng Yan

    International Journal of Colorectal Disease (2012)

  • Analysis of HLA class I expression in progressing and regressing metastatic melanoma lesions after immunotherapy

    • Rafael Carretero
    • José M. Romero
    • Teresa Cabrera

    Immunogenetics (2008)

  • The role of cytotoxic T-lymphocytes in the prevention and immune surveillance of tumors— lessons from normal and immunodeficient mice

    • IM Svane
    • M Boesen
    • A-M Engel

    Medical Oncology (1999)

  • Selective upregulation of MHC class I expression in metastatic colonies derived from tumor clones of a murine fibrosarcoma

    • S. Pedrinaci
    • A. Garcia Lora
    • F. Garrido

    International Journal of Clinical & Laboratory Research (1999)

Download PDF

Advertisement

Explore content

  • Research articles
  • Reviews & Analysis
  • News & Comment
  • Current issue
  • Collections
  • Follow us on X
  • Sign up for alerts
  • RSS feed

About the journal

  • Journal Information
  • Open access publishing
  • About the Editors
  • Contact
  • Special Issues
  • For Advertisers
  • Subscribe

Publish with us

  • For Authors & Referees
  • Language editing services
  • Open access funding
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

British Journal of Cancer (Br J Cancer)

ISSN 1532-1827 (online)

ISSN 0007-0920 (print)

nature.com footer links

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2026 Springer Nature Limited